Skip to main content
. 2017 Dec 20;14(2):361–367. doi: 10.1080/21645515.2017.1405883

Table 3.

Multivariable Regression: Association of frailty (ref = non-frail) to 2013–2014 vaccine strains stratified by age group (adjusted for BMI and baseline log2 titers)

  < 65 years (N = 66) ≥ 65 years (N = 40)  
Variable (frail vs. non-frail) Odds Ratio 95% Confidence Interval P value Odds Ratio 95% Confidence Interval P value P value for age difference
Seroprotection at Day 21a
 H1N1 A/California/07/2009 8.79 1.78 – 43.31 0.008** 0.54 0.12 – 2.52 0.43 0.009*
 H3N2 A/Texas/50/2012 6.00 1.25 – 28.75 0.02* 0.36 0.06 – 1.99 0.23 0.014*
 B/Massachusetts/2/2012 7.79 1.15 – 52.61 0.03* 0.46 0.05 – 4.67 0.51 0.05
Seroconversionb
 H1N1 A/California/07/2009 6.86 1.55 – 30.37 0.011* 0.75 0.17 – 3.30 0.70 0.045*
 H3N2 A/Texas/50/2012 5.85 1.86 – 18.40 0.003** 0.29 0.05 – 1.73 0.17 0.005**
 B/Massachusetts/2/2012 2.68 0.81 – 8.78 0.107 0.61 0.14 – 2.68 0.51 0.221
Log2 D21 HAI antibody titersc
 H1N1 A/California/07/2009 0.55 0.15 <0.001** 0.06 0.25 0.82 0.06
 H3N2 A/Texas/50/2012 0.50 0.17 0.005** −0.26 0.17 0.15 0.002**
 B/Massachusetts/2/2012 0.29 0.14 0.05 −0.17 0.14 0.23 0.04*
*

significant at P value <0.05

**

significant after adjusting for multiple comparisons 0.05/6, P value 0.0083

aLogistic Regression: Event sizes for Seroprotecting at Day 21: H1N1 (N = 38 <65 years; N = 22 ≥65 years); H3N2: (N = 48 <65 years; N = 21 ≥65 years); B: (N = 51 <65 years; N = 29 ≥65 years)

bLogistic Regression: Event sizes for Seroconverting: H1N1 (N = 13 <65 years; N = 11 ≥65 years); H3N2: (N = 25 <65 years; N = 9 ≥65 years); B: (N = 19 <65 years; N = 12 ≥65 years)

cLinear regression equation: Log2 D21 HAI titer = B0 + B1*Frail + B2*BMI + B3*log2 baseline titer +E